Applied DNA Reports Fiscal Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall Street futures subdued as tech wobbles again; Tesla gains
- Oil heads for weekly gain with focus on Middle East supply
- U.S. producer prices rise by 1.3% month-on-month in September
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- European stocks rise, dollar set for weekly loss after yields drop
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
Applied DNA Sciences (APDN) PT Lowered to $3 at Maxim Group
August 15, 2018 8:19 AM EDTMaxim Group analyst Anthony Vendetti lowered the price target on Applied DNA Sciences (NASDAQ: APDN) to $3.00 (from $5.00) while maintaining a Buy rating.
... MoreApplied DNA Sciences (APDN) Misses Q3 EPS by 5c, Revenues Miss
August 13, 2018 4:09 PM EDTApplied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.10), $0.05 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $1 million versus the consensus estimate of $2.75 million.
Revenues decreased 43% for the third quarter of fiscal 2018 to $1.0 million, compared with $1.8 million reported in the third quarter of fiscal 2017, and remained flat as compared to revenues for the fiscal second quarter ended March 31, 2018. The year-over-year decrease in revenues is primarily attributable to shipments... More


